Abstract

Factors other than age and genetics may increase the risk of developing Alzheimer disease (AD). Accumulation of the amyloid-β (Aβ) peptide in the brain seems to initiate a cascade of key events in the pathogenesis of AD. Moreover, evidence is emerging that the sleep-wake cycle directly influences levels of Aβ in the brain. In experimental models, sleep deprivation increases the concentration of soluble Aβ and results in chronic accumulation of Aβ, whereas sleep extension has the opposite effect. Furthermore, once Aβ accumulates, increased wakefulness and altered sleep patterns develop. Individuals with early Aβ deposition who still have normal cognitive function report sleep abnormalities, as do individuals with very mild dementia due to AD. Thus, sleep and neurodegenerative disease may influence each other in many ways that have important implications for the diagnosis and treatment of AD.

Original languageEnglish
Pages (from-to)115-119
Number of pages5
JournalNature Reviews Neurology
Volume10
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Dive into the research topics of 'Sleep and Alzheimer disease pathology-a bidirectional relationship'. Together they form a unique fingerprint.

Cite this